, Tracking Stock Market Picks
Enter Symbol:

down 48.36 %

THRESHOLD PHARMACEUT (THLD) rated Buy with price target $10 by Maxim Group

Posted on: Thursday,  Sep 20, 2012  9:25 AM ET by Maxim Group

Maxim Group rated Buy THRESHOLD PHARMACEUT (NASDAQ: THLD) on 09/20/2012, when the stock price was $7.96. Since
then, THRESHOLD PHARMACEUT has lost 48.37% as of 12/07/2015's recent price of $4.11.
If you would have followed this Maxim Group's recommendation on THLD, you would have lost 48.36% of your investment in 1173 days.

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/20/2012 9:25 AM Buy
7.96 10.00
as of 12/31/2012
1 Week down  -4.10 %
1 Month down  -4.75 %
3 Months down  -41.85 %
1 YTD down  -47.11 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy